Try it
OBG · Labour: antenatal magnesium sulphate for neuroprotection
Sample itemIn a woman in preterm labour at 29 weeks, magnesium sulphate given before delivery reduces which neonatal outcome?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
A. Cerebral palsy
Antenatal magnesium sulphate given when delivery is expected before 32 weeks reduces the risk of cerebral palsy and gross motor dysfunction in survivors. Antenatal corticosteroids reduce respiratory distress, and antibiotics reduce infection. Monitoring for maternal toxicity is needed.
Option by option
A. Cerebral palsy (correct)
Correct. Magnesium has a neuroprotective effect.
B. Neonatal sepsis
Magnesium does not prevent neonatal sepsis.
C. Necrotising enterocolitis
Magnesium has no proven effect on NEC.
D. Respiratory distress syndrome
Steroids, not magnesium, reduce RDS.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More OBG questions
- Antenatal careA woman's last menstrual period began on 10 January 2026. Using Naegele's rule, what is…
- Obstetric drugsCarboprost (15-methyl PGF2α) is contraindicated in which condition?
- Hypertensive disorders of pregnancyA primigravida at 34 weeks has a blood pressure of 150/100 mmHg on two occasions and 2+…
- Obstetric immunologyAn Rh-negative mother delivers an Rh-positive baby. When should anti-D immunoglobulin be…